The impact of hepatitis C virus infection on renal allograft recipients (Q43035502)

12 November 2017

The impact of hepatitis C virus infection on renal allograft recipients (English)

1 reference

12 November 2017

1 reference

1 reference

Roth D

1

1 reference

12 November 2017

Zucker K

2

1 reference

12 November 2017

Cirocco R

3

1 reference

12 November 2017

DeMattos A

4

1 reference

12 November 2017

Burke GW

5

1 reference

12 November 2017

Nery J

6

1 reference

12 November 2017

Esquenazi V

7

1 reference

12 November 2017

Babischkin S

8

1 reference

12 November 2017

Miller J

9

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 January 1994

1 reference

12 November 2017

1 reference

12 November 2017

45

1 reference

12 November 2017

1

1 reference

12 November 2017

238-244

1 reference

https://scigraph.springernature.com/pub.10.1038/ki.1994.29

12 November 2017

0 references

cites work

Nonhepatitis B-associated liver disease in a renal transplant population

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

The clinical and pathological course of hepatitis B liver disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Impact of hepatitis on renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Liver disease in recipients of long-functioning renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Late mortality and morbidity in recipients of long-term renal allografts

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C virus in kidney recipients. Epidemiology and impact on renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

The impact of renal transplantation on the course of hepatitis B liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis B virus and hepatitis B-related viral infection in renal transplant recipients. A prospective study of 90 patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C virus infection among kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C--its prevalence in end-stage renal failure patients and clinical course after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C infection in two urban hemodialysis units

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

The prevalence of hepatitis C virus antibodies among hemodialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Detection of antibody to hepatitis C virus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Genetic organization and diversity of the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Structure and organization of the hepatitis C virus genome isolated from human carriers

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolates

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Direct single stranded sequencing from agarose of polymerase chain reaction products.

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Factors affecting the autologous mixed lymphocyte reaction in kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C-virus (HCV) antibodies in patients after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C in dialysis patients: relationship to blood transfusions, dialysis and liver disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Hepatitis C virus antibodies among risk groups in Spain

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Prevalence of Antibody to Hepatitis C Virus in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Prevalence of Antibodies to Hepatitis C Virus in the Hemodialysis Unit

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Abnormal Alanine Aminotransferase Activity Reflects Exposure to Hepatitis C Virus in Haemodialysis Patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Prevalence of antibodies to hepatitis C in dialysis patients and transplant recipients with possible routes of transmission

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Cellular Immune Response to Cytomegalovirus Infection After Renal Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Assessment of the status of cell-mediated immunity in cytomegalovirus-infected renal allograft recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Value of liver biopsy in the evaluation and management of chronic liver disease in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Transmission of hepatitis C virus by organ transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.1994.29

7 January 2021

Identifiers

DOI

10.1038/KI.1994.29

1 reference

12 November 2017

1 reference